Renaissance Technologies LLC acquired a new position in BeyondSpring Inc. (NASDAQ:BYSI – Free Report) during the second quarter, HoldingsChannel reports. The fund acquired 12,500 shares of the company’s stock, valued at approximately $30,000.
Separately, SG Americas Securities LLC bought a new stake in BeyondSpring during the 1st quarter worth about $63,000. Institutional investors and hedge funds own 40.29% of the company’s stock.
BeyondSpring Price Performance
Shares of NASDAQ BYSI opened at $2.49 on Tuesday. BeyondSpring Inc. has a 1 year low of $0.78 and a 1 year high of $4.00. The firm’s 50-day moving average is $2.09 and its 200-day moving average is $2.30.
BeyondSpring Profile
BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia.
Recommended Stories
- Five stocks we like better than BeyondSpring
- How to Evaluate a Stock Before Buying
- Whirlpool’s High Dividend Yield Is Too Good to Pass Up
- Most Volatile Stocks, What Investors Need to Know
- Holiday Spending Boom Ahead: 3 BNPL Stocks Poised for Gains
- What is the Hang Seng index?
- Boeing: A Perfect Storm of Trouble Is a Loaded Buying Opportunity
Want to see what other hedge funds are holding BYSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BeyondSpring Inc. (NASDAQ:BYSI – Free Report).
Receive News & Ratings for BeyondSpring Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondSpring and related companies with MarketBeat.com's FREE daily email newsletter.
